| 1 |
34107260 | Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5. | 2021 Jun 8 |
1 |
| 2 |
30605670 | Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5. | 2019 Jan 2 |
1 |
| 3 |
24920629 | Ischemic stroke injury is mediated by aberrant Cdk5. | 2014 Jun 11 |
1 |
| 4 |
24391960 | Cdk5 phosphorylates dopamine D2 receptor and attenuates downstream signaling. | 2013 |
1 |
| 5 |
19514267 | [Role of Cdk5 in dopamine signaling and addiction]. | 2009 Jun |
1 |
| 6 |
18829967 | Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. | 2008 Oct 1 |
4 |
| 7 |
19017804 | Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology. | 2008 Nov 25 |
3 |
| 8 |
15128856 | p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. | 2004 May 5 |
1 |
| 9 |
15542734 | Role of Cdk5 in drug abuse and plasticity. | 2004 Oct |
2 |
| 10 |
12065642 | Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. | 2002 May |
1 |
| 11 |
11013232 | Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? | 2001 Jan 5 |
1 |
| 12 |
11443123 | Cyclin-dependent kinase 5 promotes insulin exocytosis. | 2001 Sep 7 |
1 |